✦ LIBER ✦

Progress in immunoconjugate cancer therapeutics

✍ Scribed by Gillian Payne

Book ID: 114413287
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 91 KB
Volume: 3
Category: Article
ISSN: 1535-6108
DOI: 10.1016/s1535-6108(03)00057-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent Progress in Cancer Therapeutics

✍ Mihich, Enrico; Zänker, Kurt S. 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 135 KB

A fluorouridine-anti-CEA immunoconjugate

A fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft model

✍ Lisa B. Shih; Hong Xuan; Robert M. Sharkey; David M. Goldenberg 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 744 KB

## Abstract 5‐fluorouridine (FUR), an antineoplastic agent, was sitespecifically conjugated to the carbohydrate moiety of a anticarcinoembryonic antigen (CEA) monoclonal antibody (MAb) by using amino‐dextran as the intermediate carrier. The final immunoconjugate contains approximately 30‐35 molecul

Hedgehog Signaling Pathway and Cancer Th

Hedgehog Signaling Pathway and Cancer Therapeutics: Progress to Date

✍ Ruch, Joshua M.; Kim, Edward J. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 363 KB

Therapeutic Progress in Ovarian Cancer,

Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas

📂 Article 📅 1981 🏛 Nature Publishing Group 🌐 English ⚖ 210 KB

ChemInform Abstract: Progress in Antisen

ChemInform Abstract: Progress in Antisense Therapeutics

✍ S. T. CROOKE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 22 KB

Targeted therapeutics for cancer treatme

Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine

✍ Paul Workman; Johann de Bono 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 124 KB